NDC 44087-3322
REBIF REBIDOSE
Interferon Beta-1a
REBIF REBIDOSE is a Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Emd Serono, Inc.. The primary component is Interferon Beta-1a.
Product ID | 44087-3322_0b175df7-7507-4d2f-bddf-65f707392420 |
NDC | 44087-3322 |
Product Type | Human Prescription Drug |
Proprietary Name | REBIF REBIDOSE |
Generic Name | Interferon Beta-1a |
Dosage Form | Injection, Solution |
Route of Administration | SUBCUTANEOUS |
Marketing Start Date | 2012-12-21 |
Marketing Category | BLA / BLA |
Application Number | BLA103780 |
Labeler Name | EMD Serono, Inc. |
Substance Name | INTERFERON BETA-1A |
Active Ingredient Strength | 22 ug/.5mL |
Pharm Classes | Interferon-beta [CS],Recombinant Human Interferon beta [EPC],Recombinant Proteins [CS] |
NDC Exclude Flag | N |
Listing Certified Through | 2021-12-31 |